Actinogen Medical Limited carries a market capitalization of 2.87M, placing it among publicly traded companies globally.
| Market Cap | 2.87M |
| Enterprise Value | N/A |
Actinogen Medical Limited's stock has declined approximately -92% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.03.
| Beta (5Y) | N/A |
| 52-Week Price Change | -92% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.03 |
| Average Volume (20 Days) | N/A |
Actinogen Medical Limited's most recent stock split took place on September 27, 2023 with a 1000:1041 split ratio.
| Last Split Date | 9/27/2023 |
| Split Ratio | 1000:1041 |